GFAP and Alzheimer disease: Plasma glial fibrillary acidic protein (GFAP), a marker associated with astrocytic reactivity, is another promising blood‐based AD biomarker that relates strongly to Aβ pathology and begins to increase early in the course of AD.10, 11, 12